{"id":"https://openalex.org/W4390734556","doi":"https://doi.org/10.1093/oncolo/oyad333","title":"A Systematic Review of Clinical Applications of Anti-CD20 Radioimmunotherapy for Lymphoma","display_name":"A Systematic Review of Clinical Applications of Anti-CD20 Radioimmunotherapy for Lymphoma","publication_year":2024,"publication_date":"2024-01-11","ids":{"openalex":"https://openalex.org/W4390734556","doi":"https://doi.org/10.1093/oncolo/oyad333","pmid":"https://pubmed.ncbi.nlm.nih.gov/38207010","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10994254"},"language":"en","primary_location":{"id":"doi:10.1093/oncolo/oyad333","doi":"https://doi.org/10.1093/oncolo/oyad333","is_oa":true,"landing_page_url":"https://doi.org/10.1093/oncolo/oyad333","pdf_url":"https://academic.oup.com/oncolo/advance-article-pdf/doi/10.1093/oncolo/oyad333/55466427/oyad333.pdf","source":{"id":"https://openalex.org/S15523509","display_name":"The Oncologist","issn_l":"1083-7159","issn":["1083-7159","1549-490X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316295","host_organization_name":"AlphaMed Press","host_organization_lineage":["https://openalex.org/P4310316295"],"host_organization_lineage_names":["AlphaMed Press"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Oncologist","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://academic.oup.com/oncolo/advance-article-pdf/doi/10.1093/oncolo/oyad333/55466427/oyad333.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043603564","display_name":"Michael Durando","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I138006243","display_name":"University of Arizona","ror":"https://ror.org/03m2x1q45","country_code":"US","type":"education","lineage":["https://openalex.org/I138006243"]},{"id":"https://openalex.org/I4210132436","display_name":"Fargo VA Health Care System","ror":"https://ror.org/03d0nge43","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210117924","https://openalex.org/I4210132436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Durando","raw_affiliation_strings":["Division of Hematology and Oncology, University of Arizona School of Medicine , Tucson, AZ , USA","Fargo VA Health Care System , Fargo, ND , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, University of Arizona School of Medicine , Tucson, AZ , USA","institution_ids":["https://openalex.org/I138006243"]},{"raw_affiliation_string":"Fargo VA Health Care System , Fargo, ND , USA","institution_ids":["https://openalex.org/I4210132436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004025497","display_name":"Ajay K. Gopal","orcid":"https://orcid.org/0000-0003-3023-6834","observed_orcids":["https://orcid.org/0000-0003-3023-6834"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ajay K Gopal","raw_affiliation_strings":["Department of Internal Medicine, Division of Hematology and Oncolog, University of Washington School of Medicine , Seattle, WA , USA","Fred Hutchinson Cancer Research Center , Seattle, WA , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Division of Hematology and Oncolog, University of Washington School of Medicine , Seattle, WA , USA","institution_ids":["https://openalex.org/I201448701"]},{"raw_affiliation_string":"Fred Hutchinson Cancer Research Center , Seattle, WA , USA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045079164","display_name":"Joseph M. Tuscano","orcid":"https://orcid.org/0000-0002-0522-1406","observed_orcids":["https://orcid.org/0000-0002-0522-1406"]},"institutions":[{"id":"https://openalex.org/I4210160527","display_name":"University of California Davis Medical Center","ror":"https://ror.org/05t6gpm70","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210160527","https://openalex.org/I4210160856"]},{"id":"https://openalex.org/I84218800","display_name":"University of California, Davis","ror":"https://ror.org/05rrcem69","country_code":"US","type":"education","lineage":["https://openalex.org/I84218800"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph Tuscano","raw_affiliation_strings":["Division of Malignant Hematology/Cellular Therapy and Transplantation, University of California Davis School of Medicine , Sacramento, CA , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Malignant Hematology/Cellular Therapy and Transplantation, University of California Davis School of Medicine , Sacramento, CA , USA","institution_ids":["https://openalex.org/I4210160527","https://openalex.org/I84218800"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5073861459","display_name":"Daniel Oscar Persky","orcid":"https://orcid.org/0000-0002-3483-2142","observed_orcids":["https://orcid.org/0000-0002-3483-2142"]},"institutions":[{"id":"https://openalex.org/I138006243","display_name":"University of Arizona","ror":"https://ror.org/03m2x1q45","country_code":"US","type":"education","lineage":["https://openalex.org/I138006243"]},{"id":"https://openalex.org/I4390039223","display_name":"University of Arizona Cancer Center","ror":"https://ror.org/04tvx8690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039223"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Daniel Persky","raw_affiliation_strings":["Division of Hematology and Oncology, University of Arizona School of Medicine , Tucson, AZ , USA","University of Arizona Cancer Center , Tucson, AZ , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, University of Arizona School of Medicine , Tucson, AZ , USA","institution_ids":["https://openalex.org/I138006243"]},{"raw_affiliation_string":"University of Arizona Cancer Center , Tucson, AZ , USA","institution_ids":["https://openalex.org/I4390039223"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5073861459"],"corresponding_institution_ids":["https://openalex.org/I138006243","https://openalex.org/I4390039223"],"apc_list":{"value":4045,"currency":"USD","value_usd":4045},"apc_paid":{"value":4045,"currency":"USD","value_usd":4045},"fwci":0.857,"has_fulltext":true,"cited_by_count":14,"citation_normalized_percentile":{"value":0.63997374,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":98,"max":99},"biblio":{"volume":"29","issue":"4","first_page":"278","last_page":"288"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.5557000041007996,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.5557000041007996,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.4368000030517578,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lymphoma","display_name":"lymphoma","score":0.7260000109672546},{"id":"https://openalex.org/keywords/90y-ibritumomab-tiuxetan","display_name":"90Y-ibritumomab tiuxetan","score":0.9200000166893005},{"id":"https://openalex.org/keywords/131i-tositumomab","display_name":"131I-tositumomab","score":0.9789999723434448},{"id":"https://openalex.org/keywords/refractory-lymphoma","display_name":"refractory lymphoma","score":0.9079999923706055},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.5339999794960022},{"id":"https://openalex.org/keywords/long-term-remission","display_name":"long-term remission","score":0.8230000138282776},{"id":"https://openalex.org/keywords/pretargeting","display_name":"pretargeting","score":0.8500000238418579},{"id":"https://openalex.org/keywords/pretreatment-biomarkers","display_name":"pretreatment biomarkers","score":0.5419999957084656},{"id":"https://openalex.org/keywords/treatment-sequencing","display_name":"treatment sequencing","score":0.4399999976158142}],"concepts":[{"id":"https://openalex.org/C2776146153","wikidata":"https://www.wikidata.org/wiki/Q7281276","display_name":"Radioimmunotherapy","level":4,"score":0.9025219678878784},{"id":"https://openalex.org/C2778515704","wikidata":"https://www.wikidata.org/wiki/Q635415","display_name":"Ibritumomab tiuxetan","level":5,"score":0.8206782341003418},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.812382161617279},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7635285258293152},{"id":"https://openalex.org/C2777058707","wikidata":"https://www.wikidata.org/wiki/Q123251","display_name":"Follicular lymphoma","level":3,"score":0.6676074862480164},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.6441612839698792},{"id":"https://openalex.org/C18031839","wikidata":"https://www.wikidata.org/wiki/Q5009796","display_name":"CD20","level":3,"score":0.6123671531677246},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5689935684204102},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5613650679588318},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.44614025950431824},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.27313339710235596},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.19097113609313965},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.07800549268722534},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000532","qualifier_name":"radiotherapy","is_major_topic":true},{"descriptor_ui":"D015021","descriptor_name":"Yttrium Radioisotopes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016393","descriptor_name":"Lymphoma, B-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016499","descriptor_name":"Radioimmunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1093/oncolo/oyad333","doi":"https://doi.org/10.1093/oncolo/oyad333","is_oa":true,"landing_page_url":"https://doi.org/10.1093/oncolo/oyad333","pdf_url":"https://academic.oup.com/oncolo/advance-article-pdf/doi/10.1093/oncolo/oyad333/55466427/oyad333.pdf","source":{"id":"https://openalex.org/S15523509","display_name":"The Oncologist","issn_l":"1083-7159","issn":["1083-7159","1549-490X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316295","host_organization_name":"AlphaMed Press","host_organization_lineage":["https://openalex.org/P4310316295"],"host_organization_lineage_names":["AlphaMed Press"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Oncologist","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10994254","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10994254","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10994254/pdf/oyad333.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncologist","raw_type":"Text"},{"id":"pmid:38207010","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38207010","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The oncologist","raw_type":"Systematic Review"}],"best_oa_location":{"id":"doi:10.1093/oncolo/oyad333","doi":"https://doi.org/10.1093/oncolo/oyad333","is_oa":true,"landing_page_url":"https://doi.org/10.1093/oncolo/oyad333","pdf_url":"https://academic.oup.com/oncolo/advance-article-pdf/doi/10.1093/oncolo/oyad333/55466427/oyad333.pdf","source":{"id":"https://openalex.org/S15523509","display_name":"The Oncologist","issn_l":"1083-7159","issn":["1083-7159","1549-490X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316295","host_organization_name":"AlphaMed Press","host_organization_lineage":["https://openalex.org/P4310316295"],"host_organization_lineage_names":["AlphaMed Press"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Oncologist","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4390734556.pdf","grobid_xml":"https://content.openalex.org/works/W4390734556.grobid-xml"},"referenced_works_count":78,"referenced_works":["https://openalex.org/W1971567636","https://openalex.org/W2003846651","https://openalex.org/W2011288702","https://openalex.org/W2012046272","https://openalex.org/W2020214604","https://openalex.org/W2042725832","https://openalex.org/W2060376769","https://openalex.org/W2080742973","https://openalex.org/W2085346499","https://openalex.org/W2092101307","https://openalex.org/W2097145287","https://openalex.org/W2106169155","https://openalex.org/W2107990794","https://openalex.org/W2110646221","https://openalex.org/W2113228924","https://openalex.org/W2113950318","https://openalex.org/W2115968060","https://openalex.org/W2127249281","https://openalex.org/W2132443196","https://openalex.org/W2136219208","https://openalex.org/W2152911354","https://openalex.org/W2165366552","https://openalex.org/W2169209759","https://openalex.org/W2170747059","https://openalex.org/W2201077658","https://openalex.org/W2298728521","https://openalex.org/W2345410310","https://openalex.org/W2534414659","https://openalex.org/W2611507725","https://openalex.org/W2765505415","https://openalex.org/W2784962174","https://openalex.org/W2790380171","https://openalex.org/W2799446051","https://openalex.org/W2810716819","https://openalex.org/W2955882040","https://openalex.org/W2983890703","https://openalex.org/W2993866869","https://openalex.org/W2999776375","https://openalex.org/W3009303057","https://openalex.org/W3011485479","https://openalex.org/W3041648365","https://openalex.org/W3047410973","https://openalex.org/W3085413652","https://openalex.org/W3087831019","https://openalex.org/W3197153138","https://openalex.org/W3205193566","https://openalex.org/W4210961312","https://openalex.org/W4220996821","https://openalex.org/W4252280335","https://openalex.org/W4382681353","https://openalex.org/W6642661554","https://openalex.org/W6653214440","https://openalex.org/W6653412999","https://openalex.org/W6655733787","https://openalex.org/W6661018975","https://openalex.org/W6665855017","https://openalex.org/W6673763898","https://openalex.org/W6674686482","https://openalex.org/W6676577419","https://openalex.org/W6677533482","https://openalex.org/W6678858905","https://openalex.org/W6679771534","https://openalex.org/W6680293945","https://openalex.org/W6682750259","https://openalex.org/W6684269068","https://openalex.org/W6685027362","https://openalex.org/W6697609308","https://openalex.org/W6704549281","https://openalex.org/W6729001474","https://openalex.org/W6748695192","https://openalex.org/W6751235373","https://openalex.org/W6765115583","https://openalex.org/W6769782648","https://openalex.org/W6770034477","https://openalex.org/W6780676479","https://openalex.org/W6802668095","https://openalex.org/W6808024500","https://openalex.org/W6853489005"],"related_works":["https://openalex.org/W2154167231","https://openalex.org/W2024642244","https://openalex.org/W2002188485","https://openalex.org/W2032191337","https://openalex.org/W7099997670","https://openalex.org/W4315481764","https://openalex.org/W4239592971","https://openalex.org/W2082292083","https://openalex.org/W4392236970","https://openalex.org/W68959763"],"abstract_inverted_index":{"PURPOSE:":[0],"The":[1,60,80,125,208],"clinical":[2,89,93,111,126,138],"efficacy":[3,112,127],"of":[4,13,25,51,82,96,104,115,130,203,210,238,244],"anti-CD20":[5,97,131,193],"radioimmunotherapy":[6],"(RIT)":[7],"is":[8,227],"due":[9],"to":[10,23,86,196,222],"a":[11,201,219],"combination":[12,209],"extracellular":[14],"mechanisms":[15,21],"involving":[16],"immune-mediated":[17],"cytotoxicity,":[18],"and":[19,28,45,71,91,107,113,117,128,140,153,166,169,181,214,242],"intracellular":[20],"related":[22],"inhibition":[24],"CD20":[26],"signaling":[27],"DNA":[29],"damage":[30],"from":[31],"ionizing":[32],"radiation.":[33],"In":[34,186],"2002,":[35],"the":[36,42,49,88,110,187,247],"first":[37],"RIT":[38,98,132,158,194,218,233,245],"was":[39,85,122],"approved":[40,62],"by":[41],"U.S.":[43],"Food":[44],"Drug":[46],"Administration":[47],"for":[48,99],"treatment":[50,215,248],"patients":[52,149,204],"with":[53,150,200],"indolent":[54],"B-cell":[55],"follicular":[56,151],"non-Hodgkin":[57],"lymphoma":[58],"(NHL).":[59],"2":[61,188],"agents,":[63],"90":[64],"Y-ibritumomab":[65],"tiuxetan":[66],"(90Y-IT,":[67],"Zevalin,":[68],"Acrotech":[69],"Biopharma)":[70],"131":[72,120],"I-tositumomab":[73],"(131-IT,":[74],"Bexxar,":[75],"GlaxoSmithKline)":[76],"both":[77],"target":[78],"CD20.":[79],"aim":[81],"this":[83],"study":[84],"review":[87,103],"applications":[90],"supporting":[92],"trial":[94],"data":[95],"lymphoma.":[100],"METHODS:":[101],"A":[102],"published":[105],"articles":[106],"abstracts":[108],"on":[109,232,236],"safety":[114,129],"90Y-IT":[116],"iodine":[118],"I":[119],"tositumomab":[121],"performed.":[123],"RESULTS:":[124],"have":[133,144],"been":[134],"demonstrated":[135,160],"in":[136,148,154,163,246],"numerous":[137],"trials":[139],"case":[141],"series.":[142],"Agents":[143],"produced":[145],"significant":[146],"responses":[147],"NHLs":[152],"off-label":[155],"applications.":[156],"Importantly,":[157],"has":[159],"promising":[161],"findings":[162],"high-risk":[164],"lymphomas":[165],"heavily":[167],"pretreated":[168],"refractory":[170],"patient":[171],"populations.":[172],"Associated":[173],"toxicity":[174],"profiles":[175],"are":[176],"noted":[177],"as":[178],"tolerable,":[179],"acceptable,":[180],"most":[182],"often":[183],"reversible.":[184],"CONCLUSIONS:":[185],"decades":[189],"since":[190],"its":[191],"approval,":[192],"continues":[195],"demonstrate":[197],"efficacy,":[198,212],"particularly":[199],"proportion":[202],"maintaining":[205],"long-term":[206,239],"remissions.":[207],"prolonged":[211],"tolerability,":[213],"convenience":[216],"makes":[217],"reasonable":[220],"alternative":[221],"other":[223],"systemic":[224],"therapies.":[225],"It":[226],"recommended":[228],"that":[229],"further":[230],"research":[231],"should":[234],"focus":[235],"biomarkers":[237],"response,":[240],"pretargeting,":[241],"sequencing":[243],"course.":[249]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":10}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-01-13T00:00:00"}